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Phenotypic Characterization of Leukocytes
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Christopher Schuster1, Christine Vaculik1, Marion Prior1, Christian Fiala2, Michael Mildner3,
Wolfgang Eppel4, Georg Stingl1 and Adelheid Elbe-Bu¨rger1
The adult human skin harbors a variety of leukocytes providing immune surveillance and host defense, but
knowledge about their ontogeny is scarce. In this study we investigated the number and phenotype of
leukocytes in prenatal human skin (dermal dendritic cells (DDCs), macrophages, T cells (including FoxP3þ
regulatory T cells), and mast cells) to unravel their derivation and to get a clue as to their putative function
in utero. By flow cytometry and immunofluorescence, we found a distinction between CD206þCD1cþCD11cþ
DDCs and CD206þCD209þCD1c skin macrophages by 9 weeks estimated gestational age (EGA). T cells appear
at the end of the first trimester, expressing CD3 intracytoplasmatically. During midgestation, CD3þFoxP3 and
CD3þFoxP3þ cells can exclusively be found in the dermis. Similarly, other leukocytes such as CD117þ (c-kit)
mast cells were not identified before 12–14 weeks EGA and only slowly acquire a mature phenotype during
gestation. Our data show at which time point during gestation antigen-presenting cells, T cells, and mast cells
populate the human dermis and provide a step forward to a better understanding of the development of the
human skin immune system.
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INTRODUCTION
The dermis harbors a variety of leukocytes, which interact to
provide immune surveillance and host defense (Bangert et al.,
2011; Teunissen et al., 2012). Recently, we reported that
CD45þHLA-DRþ leukocytes are already present by 9 weeks
estimated gestational age (EGA) in human embryonic skin
and that their development and attraction depends on various
growth and differentiation factors present in developing skin,
leading to the sequential acquisition of the phenotypic
repertoire, exemplified by the development of epidermal
Langerhans cells (Schuster et al., 2009). Despite these recent
advances in the understanding of the development of the skin
immune system, the leukocytes of the embryonic and fetal
human dermis have remained poorly characterized. In
particular, our understanding of the diversity, origin as well
as function of antigen-presenting cells (APCs) and mast cells
along with the development of cells of the adaptive immunity
in skin is still scarce and needs further elucidation.
Dermal dendritic cells (DDCs) and skin macrophages
are APCs that share a similar surface marker profile. They
express HLA-DR and various monocyte/macrophage markers
(e.g., CD11c, CD14, CD36, CD68, FXIIIa, or CD206
(mannose receptor)) to a varying extent (Meunier et al.,
1993; Nestle et al., 1993; Ebner et al., 2004; Angel et al.,
2007; Zaba et al., 2009; Geissmann et al., 2010). Yet, these
markers have failed to unambiguously distinguish between
DDCs and macrophages. Recently, Zaba et al. (2007)
proposed CD1c (BDCA-1) as a reliable marker for resident
skin DCs. Controversy exists about the expression of CD209
(DC-SIGN), which has been described by some groups
as a specific marker for skin macrophages (Ochoa et al.,
2008; Canard et al., 2011), while other groups find
co-expression with DDC subsets (Geijtenbeek et al., 2000;
Zaba et al., 2007). With regard to the distinction of
macrophages and dermal DCs in prenatal skin, we and
others have shown that CD36þ , CD1cþ , FXIIIaþ , and HLA-
DRþ cells can be identified during the first trimester, but
detection of co-expression and inclusion of other markers is
necessary to gain better insight into their development (Foster
et al., 1986; Fujita et al., 1991; Gibran et al., 1996; Schuster
et al., 2009).
As part of the adaptive immune system, T cells fulfill
important roles in immunosurveillance (Foster and Elbe,
1997; Clark et al., 2006; Clark, 2010). In adult skin, a large
pool of trafficking memory T cells allows for a rapid response
in case of antigenic challenge. The entry of T cells into skin is
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a multistep process, initialized by the binding of cutaneous
lymphocyte-associated antigen (CLA)-positive T cells to
E-selectin on post capillary venules (Chong et al., 2004).
CCL17/thymus and activation-regulated chemokine (Hijnen
et al., 2004; Saeki and Tamaki, 2006) and CCL27/cutaneous
T-cell-attracting chemokine (Morales et al., 1999) have a
central role for the attraction of T cells. Of note, CCL27, a
chemokine constitutively produced in skin by epidermal
keratinocytes, selectively attracts CLAþCCR10þ memory
T cells into skin (Morales et al., 1999). In contrast to the well-
studied ontogeny of T cells in fetal liver, spleen, and thymus,
the phenotype of T cells in human prenatal skin has been
poorly investigated. While ultrastructural studies failed to
detect T cells in developing skin (Breathnach, 1977), a recent
report identified naive T cells (CD4þ4CD8þ ) at 18 weeks
EGA using immunohistochemistry (Di Nuzzo et al., 2009). In
the course of the development of the immune system, T cells
are selected or regulated to become tolerant to self-antigens
and reactive against foreign antigens. In addition to the
deletion of self-reactive cells, it has been demonstrated that
regulatory T cells increase in numbers during the very early
stages of pregnancy and help to suppress fetal immune
responses in humans (Sasaki et al., 2004; Somerset et al.,
2004; Jasper et al., 2006; Mold et al., 2008; Tilburgs et al.,
2008; Yang et al., 2008).
Information about mast cell ontogeny in human prenatal
skin is scarce (Fujita et al., 1969; Breathnach, 1978; Omi
et al., 1991). Mast cells are bone marrow–derived cells
expressing the pan-leukocyte marker CD45 as well as CD117
(c-kit; Metcalfe et al., 1997). Their function in skin is
essentially unknown, but probably involves both homeostatic
regulation of nerves and blood vessels, as well as host
defense (Galli et al., 2008). The most characteristic feature of
mature mast cells is cytoplasmic granules, which contain
numerous preformed mediators that are released at the time
of stimulation. Proteoglycans within the mast cell granule
permit the binding of a variety of cationic dyes, such as
toluidine blue or Giemsa, which stain the mast cell
metachromatically. Additionally, antibodies specific for two
granule-associated serine proteases, tryptase and chymase,
can be used to identify skin mast cells (Irani et al., 1989).
Ultrastructural studies performed in the seventies and eighties
of the last century identified unanimous mast cells at around
20–26 weeks EGA, containing specific granules as well as
immature pre-stages (Omi et al., 1991). During the first
trimester, only cells containing small vesicles with no clearly
recognizable granules were rarely observed ultrastructurally
representing either melanoblasts or immature mast cells
(Breathnach, 1978).
Given that our understanding of multiple aspects of the
development of the skin immune system is incomplete in
humans and that the situation in mice differs in significant
aspects (Fadel and Sarzotti, 2000; Adkins et al., 2004; Levy,
2007; Elbe-Bu¨rger and Schuster, 2010), we believe that the
study of the ontogeny of skin leukocytes has the potential to
yield valuable information about the origin and relationship
of skin leukocytes and the general status of the skin immune
system in utero.
RESULTS
Embryonic skin contains significant populations
of DDCs and macrophages
To assess whether macrophages in prenatal human dermis
express important lineage molecules, skin of defined gesta-
tional age groups and, in parallel, of adults was immuno-
stained for CD45, CD206, and CD209. Similar to adult skin,
CD45þCD206þCD209þ cells (Figure 1, arrows), most
probably macrophages, as well as CD45þCD206þCD209
cells (Figure 1, arrrowheads) are identified already in
embryonic dermis. The staining intensity of CD206 and
CD209 in embryonic skin is mostly comparable to adult skin,
yet some cells show only weak expression (compare Figure 2,
left column, arrowhead), implying that the upregulation of
these markers occurs in the skin. Of note, CD206 staining
of linear structures, most likely blood vessels, is observed
occasionally in prenatal but not in adult skin (Figure 1,
middle column, double arrow). Epidermal CD45þ cells at all
age groups investigated lack CD206 and CD209. To evaluate
whether CD1c and CD209 are mutually exclusive, triple
immunofluorescence staining was performed. We found
virtually nonoverlapping populations of CD206þCD1cþ
DDCs (Figure 2, arrowhead) and CD206þCD209þ macro-
phages (arrow) already in prenatal dermis, similar to what has
been reported in adult dermis, with the exception that
CD1cþ cells more often lack or weakly express CD206.
Statistical analysis revealed that the frequency of CD1cþ
leukocytes significantly increases with gestational age (Figure
2b) and that CD209þ cells outnumber CD1cþ cells between
9 and 14 weeks EGA, reaching adult-like ratios already by
midgestation (Figure 2c). By flow cytometry, we found that in
all age groups investigated CD11cþ cells are detectable and
that CD11c expression is restricted to CD45þ leukocytes
(Figure 3a). In depth analysis of HLA-DRhighCD45þ cells
reveals that CD1cþCD11cþ cells are already present in the
developing skin. The HLA-DRhighCD45þ population con-
tains a similar percentage of CD1cCD11cþ cells but, in
contrast to adult skin, a higher percentage of CD1cCD11c
cells (Figure 3b, R1). In addition, HLA-DRlow/negCD45þ cells
express CD11c to a similar extent at all time points
investigated (Figure 3b, R2 and R3).
FoxP3þ T cells are present in fetal human skin
CD45þCD3þ T cells were not detectable in skin during the
first trimester in six out of eight samples (Figure 4a-c),
whereas two samples (11 and 14 weeks EGA) show a minute
population, comprising 0.01% of total skin single cell
suspensions. In these embryonic samples, CD3 was rarely
found by immunofluorescence and seemed to be expressed
only intracellulary (Figure 4b). During midgestation, a
moderate increase in T cells takes place, but numbers are
approximately 15- to 20-fold lower than in adult skin.
CD3þCD45þ cells are exclusively found in the dermis
during skin development.
Given the prominent role of CCL27 in the cutaneous
recruitment of memory T cells, we analyzed skin cell culture
supernatants from embryonic, fetal, and adult single cells,
and found that CCL27 concentrations are significantly higher
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in adult than in embryonic and fetal skin (Figure 4d). In line
with these data, immunohistochemical analysis of CCL27
expression revealed a lower staining intensity in fetal
compared with adult epidermis (Figure 4e). Of note, skin
appendages in fetal skin showed a similar staining intensity as
adult skin (data not shown). Taken together, these findings
indicate that fetal keratinocytes produce less CCL27 than
adult keratinocytes. As the majority of skin-homing T cells in
fetal skin are naive (Di Nuzzo et al., 2009) and, thus, not
attracted by CCL27 (Morales et al., 1999), our finding
suggests that the influx of predominately naive T cells during
skin development might be independent of CCL27.
Given the key role of regulatory T cells controlling and
maintaining tolerance to self-antigens and the linkage of
FoxP3 to this function, we further investigated whether these
cells may already be present in prenatal skin. Indeed, FoxP3
expression was found in 20.0% (SD 6.5%; n¼ 5) of all T cells
(5.9 CD3þ cells cm1, SD 2.9; n¼5), a frequency compar-
able to what is found in the adult skin (Figure 5; Clark and
Kupper, 2007; Agius et al., 2009).
Immature mast cells appear during the first trimester
By flow cytometry, CD45þCD117þ mast cells are not
detectable in human prenatal skin until 11 weeks EGA
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Figure 1. CD45þCD206þCD209þ and CD45þCD206þCD209 cells are present in embryonic dermis. Immunofluorescence triple staining was performed
on cryostat sections of embryonic, fetal, and adult skin. Arrows indicate triple positive cells, arrowheads CD45þCD206þ double-positive cells, and double
arrows indicate CD206þ vascular structures. One of at least three experiments per group is shown. Bars¼ 50 mm. EGA, estimated gestational age.
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Figure 2. CD206þCD1cþ DDCs can be distinguished from CD206þCD209þ skin macrophages in embryonic skin. (a) Arrows indicate CD206þCD209þ
cells, and arrowheads indicate CD1cþ DCs in all indicated age groups. One of at least four experiments per group is shown. Bars¼ 50mm. (b) Dot graph shows
the increase of CD45þCD1cþ cells in developing skin using flow cytometry. (c) Shown are relative numbers of CD1cþ and CD209þ dermal cells at selected
developmental time points analyzed by immunoflourescence (n¼4–5 per group). DC, dendritic cell; DDC, dermal dendritic cell; EGA, estimated gestational age.
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Figure 3. CD11cþ leukocytes are present throughout skin development. (a, b) Multiparameter flow cytometry of freshly isolated single cell suspensions of
embryonic, fetal, and adult skin was performed by incubation with mAbs against the cell surface markers indicated. Gates in dot plots were set according
to isotype-matched control staining. Dead cells were excluded by 7-amino-actinomycin-D uptake. Dot plots are representative of 3–6 experiments.
(b) CD45þHLA-DRhigh (R1), CD45þHLA-DRweak (R2), and CD45þHLA-DR (R3) cells from the indicated age groups are compared with regard to
expression of CD11c and CD1c (lower panels). EGA, estimated gestational age.
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(Figure 6a and b). Coinciding with the beginning of bone
marrow hematopoiesis a minute, though distinct, population
of mast cells can be first identified at 12–14 weeks EGA. The
frequency of CD45þCD117þ cells increases considerably
during the second trimester, occasionally reaching adult-like
levels (Figure 6a and b). A comparison of the scatter profiles
Figure 4. Skin T cells can be identified at midgestation. (a) Multiparameter flow cytometric analysis was performed after incubation with mAbs against the cell
surface markers indicated. Gates in dot plots were set according to isotype-matched control staining. Dead cells were excluded by 7-amino-actinomycin-D
uptake. Dot plots are representative of 5–8 experiments. (b) Immunofluorescence double staining was performed on cryostat sections of embryonic, fetal, and
adult skin. One of at least three experiments per group is shown. Arrows denote CD45þCD3þ T cells. (c) Graphs show an increase of T-cell numbers in
developing prenatal skin analyzed by flow cytometry (n¼ 5–8). (d) Single cell suspensions of embryonic, fetal, and adult skin were cultured for 48 hours,
supernatants were harvested, and CCL27 levels were analyzed by ELISA. Bars represent the mean. (e) Immunohistochemical staining was performed on cryostat
sections of fetal and adult skin, and CCL27 binding was visualized using amino-ethyl-carbazole. Bars¼50 mm. EGA, estimated gestational age.
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Figure 5. FoxP3þ T cells are present in fetal human skin. Immunofluorescence double staining was performed on cryostat sections of fetal skin (n¼ 5). Arrows
denote CD3þFoxP3 T cells (left panel) and CD3þFoxP3þ T cells (middle panel). Arrowheads indicate intracellular FoxP3 staining in the insert. Demonstration
of a FoxP3þ and a FoxP3 T cell on the same section (right panel). Bars¼50 mm, bar in inset¼ 20mm. DAPI, 4,6-diamidino-2-phenylindole; EGA, estimated
gestational age.
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of fetal and adult CD45þCD117þ skin mast cells reveals a
substantially weaker granularity of fetal than adult mast cells
(Figure 6c, red dots), indicating immaturity of fetal mast
cells due to the lack of specific granules. By contrast,
CD45þCD3þ T cells in fetal and adult skin have a similar
forward and side scatter profile, but significantly differ in
numbers (Figure 6c, green dots). In line with the suspected
mast cell immaturity, we could not detect mast cells by their
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Figure 6. Mast cells appear during the first trimester but are not fully mature at midgestation. (a) Flow cytometric analysis of freshly isolated single cell
suspensions of embryonic, fetal, and adult skin revealed the presence of immature mast cells in fetal skin. Shown are representative dot plots of five experiments per
group. (b) Graphs show the increase in mast cell numbers of developing skin analyzed by flow cytometry. Five specimens were investigated per age group. Bars
represent the mean of investigated groups. (c) The size, granularity, and numbers of CD45þCD117þ cells (red dots) and CD45þCD3þ cells (green dots) between
fetal and adult skin are compared. (d, e) Toluidin blue (d) and chymase (e) stainings were performed on cryostat sections of embryonic, fetal, and adult skin
(left panel). Arrows denote toluidine blue-expressing cells in fetal dermis. Bar¼ 100mm. The numbers of metachromatic cells (d, right panel) and chymaseþ cells
(e, right panel) were determined and bars represent the mean of investigated groups (n¼ 5–6 per group). EGA, estimated gestational age; FCS, forward scatter;
SSC, side scatter.
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metachromatic staining with toluidin blue up to 14 weeks
EGA (Figure 6d). Toluidin blue–expressing cells were first
identified in the second trimester, but their numbers were
approximately 8-fold lower than in adult skin. Similar to adult
skin, these cells are preferentially found around vessels and in
vicinity to skin appendages. Mature, chymase-expressing
mast cells are rarely found in fetal skin (Figure 6e), but can be
easily identified in adult skin. The ratio of toluidin blue/
chymase-positive cells changes from 6.4:1 in fetal skin to
0.9:1 in adult skin.
DISCUSSION
We have shown that human embryonic skin contains almost
mutually exclusive, committed CD209þ skin macrophages
and CD1cþ DDCs. In addition, we have found that important
cells of the skin immune system colonize the developing skin
at different time points, i.e., APC by 9 weeks EGA (the earliest
time point investigated), T cells during the second trimester,
and mast cells at 12 weeks EGA.
The distinction of DDCs and skin macrophages by
phenotypic terms can be difficult, owing to their high
plasticity and/or different lineage affiliation (Meunier et al.,
1993; Nestle et al., 1993; Ebner et al., 2004; Angel et al.,
2007; Zaba et al., 2009; Geissmann et al., 2010). Recently,
various groups proposed new markers for the identification of
DDCs and skin macrophages, namely CD1c and CD209,
respectively (Ochoa et al., 2008; Zaba et al., 2009; Scha¨kel
and Ha¨nsel, 2011). We show in this study that already by 9
weeks EGA skin macrophages and DCs can be phenotypi-
cally separated by the almost distinct expression of CD1c and
CD209. Of note, both populations express CD206, making
this marker suitable for detecting dermal APCs. On the basis
of the expression of these molecules and on earlier results
one may reason that both DCs and skin macrophages possess
the ability to recognize and ingest foreign antigen in case
the epithelial barrier has been breached, e.g., under the
condition of microbial invasion of the amniotic fluid. The
weak expression of CD206 on some CD1cþ cells as well as
the fact that CD206 expression is not found on potential
blood precursors (Shepherd et al., 1982) suggest an upregula-
tion of this marker in situ, which can be induced by high
levels of M-CSF and IL-6, cytokines already found in
embryonic skin (Gersuk et al., 2005; Schuster et al., 2009).
The elucidation of the origin of DCs and skin macrophages
is generally complicated by the diversity and plasticity of
DDCs. Similar to epidermal Langerhans cells, they co-express
CD11c and CD1c, yet, also a subset of CD11cþCD1c DDCs
positive for CD141 has been described (Zaba et al., 2007). In
developing skin, HLA-DRhighCD45þ cells are more hetero-
geneous with regard to the expression of CD11c and CD1c.
From an ontogenetic point of view, it is conceivable that
CD11cCD1c cells act as precursors of CD11cþCD1cþ via
CD11cþCD1c cells, especially given the higher percentage
of CD11cCD1cHLA-DRhigh leukocytes in prenatal skin.
Whether these cells express CD141 remains to be investigated.
T cells are the prototypical cells of the adaptive immune
system. In adult, noninflamed skin, the majority of resident
T cells are CLAþCD45ROþ memory cells, which are recruited
into skin mainly by two chemokines, CCL27 and CCL17
(Morales et al., 1999; Clark et al., 2006; Saeki and Tamaki,
2006). During in utero development, T-cell precursors are
first detectable in the fetal liver at 7 weeks of gestation and
are found in the developing thymus and circulation by 8–9
weeks EGA (Campana et al., 1989; Holt and Jones, 2000).
With regard to function, alloreactivity is found in the fetal
liver at 7 weeks EGA and T cells are believed to be immu-
nocompetent by midgestation (Fadel and Sarzotti, 2000; Holt
and Jones, 2000; Hermann et al., 2002; Michaelsson et al.,
2006; Mold et al., 2008; Vermijlen et al., 2010). By immu-
nofluorescence, we occasionally identified CD45þCD3þ
cells in the first trimester, which appear to have intracellular
CD3 expression and were, thus, not identified by conven-
tional flow cytometry. CD3þ T cells are detectable in the
fetal circulation at about 15–16 weeks of gestation (Haynes
et al., 1988). In line with this we found that by midgestation,
CD45þCD3þ cells are present in higher numbers, yet, still in
numbers much smaller than in adult skin. Two possibilities—
or a combination thereof—may explain this observation. First,
as almost no exogenous antigen is presented in secondary
lymphatic tissues in utero, skin-homing CD45ROþ memory
cells simply do not develop. This is corroborated by the
recent finding that T cells in fetal skin have a largely naive
(CD45RAþ ) phenotype and do not express CLA, suggesting
that T cells may nonspecifically be recruited into prenatal
skin (Di Nuzzo et al., 2009). Second, it appears that
developing skin contains lower levels of CCL27 than adult
skin, thus, preventing the influx of memory T cells from the
circulation (Morales et al., 1999). The expression of other
cytokines critical for the attraction of lymphocytes in the
steady state, such as CCL17, remains to be investigated. With
regard to the phenotype of skin lymphocytes, we found that
the majority of CD3þ cells expressed CD4, thus, confirming
previous results described by Di Nuzzo et al. (2009). We
exclusively observed TCR abþCD3þ -expressing cells in fetal
human skin (C Schuster, unpublished data) making the
existence of a human analog of murine dendritic epidermal
T cells (Steiner et al., 1988) and the recently described
murine TCR gd dermal T cells (Gray et al., 2011; Sumaria
et al., 2011) in prenatal skin quite unlikely. Whether skin-
homing fetal T cells have a particular function, e.g., in
inducing or maintaining tolerance, is currently not known
(Mold et al., 2010). Of note, fetal dermatitis after microbial
invasion of the amniotic fluid results in inflammatory
infiltrates including CD3þ T cells (Kim et al., 2006). This
finding suggests that circulating T cells can be attracted under
certain conditions.
It has been shown that fetal tissues and blood contain
higher numbers of regulatory T cells to control and at least
partially maintain tolerance to self-antigens (Somerset et al.,
2004; Mold et al., 2008). We were surprised to find similar
numbers of FoxP3þ cells in fetal and adult skin, supporting the
concept for the existence of various tolerance mechanisms.
The importance of mast cells in skin immunity and
homeostasis is increasingly recognized (Metcalfe, 2008).
Early electron microscopy studies failed to detect definitive
mast cells in human first trimester skin. At the end of the first
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trimester, Breathnach (1977) identified cells of unclear
affiliation containing vesicles compatible with both melano-
blasts and mast cells. Using flow cytometry, we showed that
mast cells are not present in embryonic skin until 11 weeks
but appear after 12 weeks EGA. Yet, we also observed
CD45CD117þ cells, probably representing melanoblasts
and/or melanocytes. Of note, the appearance of
CD45þCD117þ cells coincides with the beginning of bone
marrow hematopoiesis (Tavian and Peault, 2005). Whether
these CD45þCD117þ cells are derived from the newly
formed bone marrow or are attracted from other hemato-
poietic stem cell sources due to changing microenviron-
mental factors is not known. Also hematopoietic progenitor
cells can express CD117 in certain stages of development
(Tavian and Peault, 2005). It appears quite unlikely that
CD45þCD117þ cells represent hematopoietic progenitor
cells—either as blood contamination or as resident cells in
skin—given that these cells were not observed between 9 and
11 weeks of EGA. CD45þCD117þ mast cells during the first
trimester stain neither for toluidin blue nor for chymase,
suggesting that no specific granules are present and thus
confirming earlier assumptions (Fujita et al., 1969). During
midgestation, toluidin blueþ and chymaseþ cells are first
detectable, although flow cytometric analysis using the side
scatter profile as well as the density of toluidin blue- and
chymase-staining indicates that the mast cells are immature
with regard to both granule numbers as well as granule
content. Of note, just a minority of mast cells express
chymase, whereas all cells in adult skin stain for this marker
(Irani et al., 1989). To date, nothing is known about the
functional potential of mast cells in human fetal skin.
Interestingly, we occasionally observed degranulation, prob-
ably resulting from tissue preparation and cutting. This might
indicate that mast cells already in fetal skin possess the
capacity to exert their ancestral function. In addition, it is not
known whether distinct developmental pathways or environ-
mental factors contribute to the maturation of mast cells. The
most important cytokine for mast cell development, stem cell
factor, is found at highest concentration in embryonic skin,
perhaps providing an important chemoattractant for blood-
borne precursors (Schuster et al., 2009).
Taken together, we found that the myeloid part of the
skin-resident immune system (i.e., DDCs, macrophages, mast
cells and, as described previously, epidermal Langerhans
cells (Schuster et al., 2009; Elbe-Bu¨rger and Schuster, 2010))
shows a high degree of maturity already at a prenatal stage.
Indeed, both in vitro experiments as well as in vivo
data indicate that the human fetal skin is already capable
of recognizing and responding to microbial products
(Kim et al., 2006).
MATERIALS AND METHODS
Skin samples
After legal termination of pregnancy, 42 specimens of human
embryonic and fetal trunk skin ranging from 8 to 24 weeks EGA were
studied. The age was estimated by crown-rump length and maternal
history. Healthy adult (18–59 years) skin was collected after
abdominal, back, and breast surgery. The study was approved by
the local ethics committee and conducted in accordance with the
declaration of Helsinki Principles. Parents/participants gave their
written informed consent.
Preparation of skin cell suspensions
After removal of subcutaneous tissue, embryonic, fetal, and adult skin
specimens were incubated on 1.2Uml1 Dispase II (Roche Diag-
nostics, Indianapolis, IN) in phosphate-buffered saline overnight at
4 1C. It was not possible to efficiently separate dermis and epidermis
in embryonic skin, thus unseparated skin regardless of age was
vigorously agitated in a shaking water bath in 0.53Uml1 Liberase 3
(Roche Diagnostics) in phosphate-buffered saline at 37 1C for 60 to
90min. The resulting single cell suspensions were analyzed by flow
cytometry or cultured for 48hour (106 cellsml1) in RPMI 1640
medium (Invitrogen, Eugene, OR) supplemented with 10% heat-
inactivated fetal calf serum (PromoCell, Heidelberg, Germany), 25mM
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 10mgml1 gen-
tamicin, 2mM L-glutamine, 0.1mM nonessential amino acids, 1mM
sodium pyruvate, 50mM 2-mercapto-ethanol, and 0.002% antibiotic-
antimycotic solution (all Invitrogen).
Flow cytometry
Single cell suspensions were stained with the following mAbs: PE-anti-
CD117 (YB5.B8), PE-anti-CD11c (Leu-M5), PE-anti-HLA-DR (L243;
all Becton Dickinson, Mountain View, CA), PE-Cy7-anti-CD45 (J.33;
both Beckman Coulter, Fullerton, CA), FITC-anti-CD3 (UCHT1, An
der Grub, Kaumberg, Austria), and FITC-anti-CD1c (M241; Ancell,
Bayport, MN). Appropriate isotype controls were included. Dead
cells were excluded with 7-amino-actinomycin-D (Calbiochem,
Darmstadt, Germany). Five-color flow cytometry analyses were
performed on a LSR-II (Becton Dickinson) and data were analyzed
using FlowJo software (Tree Star Inc., Ashland, OR).
Immunohistochemistry
Embryonic, fetal and adult skin specimens were embedded in
optimum cutting tissue compound (Tissue-Tek, Sakura Finetek,
Zoeterwoude, The Netherlands), snap-frozen in liquid nitrogen, and
stored at 80 1C until further processing. Six-micrometer sections
were cut, air-dried, fixed in ice-cold acetone for 10minutes and
washed in phosphate-buffered saline. Sections were then incubated
with an unconjugated anti-CCL27 mAb (124302, R&D Systems,
Minneapolis, MN) or anti-chymase mAb (B7, Millipore, Billerica, MA)
overnight at 4 1C, followed by blocking of endogenous peroxidase
activity by incubating sections for 10minutes in methanol containing
0.03% hydrogen peroxide. Subsequently, sections were incubated
for 2 hours at room temperature with biotin-conjugated goat
anti-mouse IgG using the Elite mouse IgG Vectastain Kit (Vector
Laboratories, Burlingame, CA). Biotinylated antibodies were
detected with horseradish peroxidase–streptavidin and staining
was visualized with amino-ethyl-carbazole (Dako, Glostrup, Den-
mark). Finally, sections were mounted with Aquatex (Merck,
Darmstadt, Germany) and examined using a Nikon Eclipse 80
microscope (Nikon, Tokyo, Japan). Appropriate isotype controls
(Becton Dickinson) were included.
Immunofluorescence
Fixed sections were stained with uncongujated primary antibodies
anti-CD1c (L161; Serotec, Kidlington, UK), anti-CD209 (DCN46,
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Becton Dickinson), or FoxP3 (236A/E7; eBioscience, San Diego, CA)
overnight at 4 1C and then detected with donkey-anti-mouse
NorthernLight637 (R&D Systems). Subsequently, sections were
blocked with 10% mouse serum and 2% mouse IgG (Becton
Dickinson) for 1 hour at room temperature and stained with the
following conjugated antibodies overnight at 4 1C: Alexa Flour 555-
anti-CD45 (MEM28, Exbio, Vestec, Czech Republic), Alexa Flour
555-anti-CD206 (19.2, Becton Dickinson, both labeled using the
Alexa Flour 555 Monoclonal Antibody Labeling Kit, Invitrogen),
FITC-anti-CD206 (19.2; Becton Dickinson), and FITC-anti-CD3
(UCHT1, An der Grub). Alexa Flour 488-anti-Laminin 5 (D4B5;
Millipore) was used to visualize the dermo–epidermal junction.
Slides were mounted using Vectashield (Vector Laboratories) and
images were recorded using a confocal laser scanning microscope
(LSM 410; Carl Zeiss, Jena, Germany) equipped with three lasers
emitting lights at 488, 543, and 633 nm. For FoxP3 staining, nuclear
counterstain was performed with Vectashield containing 4,6-
diamidino-2-phenylindole (Vector Laboratories).
Cytokine determination in skin cell supernatants
Skin single cell suspensions (1x106ml1) were cultured in 24-well
plates (Costar, Lowell, MA) in RPMI 1640 supplemented as
described above. After 48 hours, supernatants were harvested,
snap-frozen and stored at 80 1C until use. CCL27 was determined
by ELISA (R&D Systems) according to the manufactures instructions.
Experiments were performed in duplicates.
Toluidin blue staining
Six micrometer frozen sections were cut, air-dried, stained in
toluidin blue O/methanol (Sigma-Aldrich, St Louis, MI) for 15
seconds. After washing in phosphate-buffered saline, the sections
were mounted with Aquatex (Merck) and examined using a Nikon
Eclipse 80 microscope (Nikon).
Quantification of cells in skin sections
FoxP3þCD3þ , chymaseþ , and toluidin blue-reactive cells were
enumerated by two independent investigators in multiple skin
sections with a total length of at least 6 cm ( 40 object lens, Carl
Zeiss;  20 object lens; Nikon).
Statistical analysis
Differences between groups were assessed with the Mann–Whitney
U test or Student’s t-test (GraphPad Software, San Diego, CA). The
reported P-value is a result of a two-sided test. A P-value o5% is
considered statistically significant.
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